LXRX LEXICON PHARMACEUTICALS, INC.

NEUTRAL Impact: 2/10 Institutional Cluster
Horizon weeks Processed 1d 19h ago
Institutional cluster: 4 buyers, 2 sellers (mixed)

Executive Summary

A weak institutional cluster in LXRX shows 4 buyers (Schwab, Two Sigma, BofA, Morgan Stanley) adding $1.2M in aggregate and 2 sellers trimming ~$25K, driven primarily by passive rebalancing and a quant model addition. The small position sizes relative to LXRX's $835M market cap and lack of active manager conviction make this a low-signal event.

Key Financial Metrics

Direction
mixed
Buy Value
$2.6M
Sell Value
$95.4K
Net Flow
$1.2M

Institutional Positions

Net institutional flow: $1.2M

▲ Buyers (4)

InstitutionActionChangePosition ValueValue Δ
Schwab ADD +29.6% $1.5M $710.0K
Two Sigma ADD +38.4% $755.0K $373.0K

▼ Sellers (2)

InstitutionActionChangePrev ValueValue Δ
Bank Of Montreal /Can TRIM -30% $95.0K -$70.00
Wells Fargo NEAR_EXIT -98.9% $25.0K -$24.6K

Actionable Insight

The cluster lacks conviction from active funds, suggesting no material catalyst has driven this activity. Monitor upcoming pipeline catalysts or earnings for potential triggers, but this 13F data is stale (Q3 2025) and may have been unwound. The near-exit by Wells Fargo is notable but isolated.

Key Facts

  • 4 institutions increased positions (net +$1.2M) while 2 reduced holdings (net -$25K)
  • Buyers are dominated by mega-passive funds (Schwab, BofA, Morgan Stanley) plus quant fund Two Sigma
  • Sellers include Bank of Montreal (trim -30%) and Wells Fargo (near-exit -98.9%)
  • Total buyer current holdings are ~$2.6M vs market cap of $835M — less than 0.3% of float

Financial Impact

4 institutions added $1.2M in new positions while 2 reduced holdings by ~$25K, net buying of ~$1.175M

institutional ownershipfloat

Risk Factors

  • 13F data has 45-day reporting lag; positions may have changed since quarter-end
  • Small absolute dollar amounts limit signal strength
  • Passive rebalancing may drive noise rather than informed trading

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
73% bullish (11 analysts)

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-LXRX-2025-Q3
10 reports for LXRX
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +26.22%Mar 5, 2026
Filters
Rows
Reports for LXRX — sortable, filterable
Type Now
Jun 12, 2026
1d ago
Institutional Cluster
BEARISH ★ 5/10
$1.90 awaiting T+20awaiting T+20
Jun 11, 2026
1d ago
Institutional Cluster
NEUTRAL ★ 2/10
$1.88 awaiting T+20awaiting T+20
May 6, 2026
5w ago
8-K
NEUTRAL ★ 4/10
$1.68 $1.85▲ +10.12%▲ +6.98%
Apr 30, 2026
6w ago
8-K
BEARISH ★ 6/10
$1.63 $2.07▼ −26.99%▼ −21.71%
Apr 30, 2026
6w ago
Press Release
NEUTRAL ★ 2/10
$1.61 $2.21▲ +37.27%▲ +32.30%
Mar 24, 2026
11w ago
Press Release
MIXED ★ 6/10
$1.72 $1.82▲ +5.81%▼ −3.09%
Mar 23, 2026
11w ago
Press Release
BULLISH ★ 7/10
$1.64 $1.83▲ +11.59%▲ +4.17%
Mar 16, 2026
12w ago
DEFA14A
NEUTRAL ★ 3/10
$1.62 $1.86▲ +14.81%▲ +10.51%
Mar 5, 2026
14w ago
8-K
BULLISH ★ 7/10
$1.64 $1.59▼ −3.05%▲ +0.74%
Mar 5, 2026
14w ago
Press Release
MIXED ★ 6/10
$1.64 $1.59▼ −3.05%▲ +0.74%
Showing 10 of 10

US Market Status

Market Closed — Opens Mon (46h 57m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access